Cited by 17Dementia and Cognitive Impairment ResearchAmyotrophic Lateral Sclerosis ResearchAlzheimer's disease research and treatments

The DOI matches its Crossref record; the references it cites are not checked yet.

Living With Frontotemporal Degeneration: Diagnostic Journey, Symptom Experiences, and Disease Impact

Open access

Abstract

Frontotemporal degeneration (FTD) is an umbrella term encompassing a range of rare neurodegenerative disorders that cause progressive declines in cognition, behavior, and personality. Hearing directly from individuals living with FTD and their care partners is critical in optimizing care, identifying meaningful clinical trial endpoints, and improving research recruitment and retention. The current paper presents a subset of data from the FTD Insights Survey, chronicling the diagnostic journey, symptoms, and the impact of FTD on distress, quality of life, and independence, in the mild to moderate stages of the disease. Survey respondents included 219 individuals diagnosed with FTD and 437 current care partners, representing a range of FTD diagnoses. Around half of survey respondents reported seeing three or more doctors before an FTD diagnosis was given, and a range of prior diagnoses were noted. Most frequently endorsed symptoms tended to be consistent with clinical characteristics of the specific diagnosis, though there was significant variability in symptoms reported within diagnostic categories as well as considerable overlap in symptoms between diagnostic categories. Cognitive and language symptoms of FTD were generally most distressing to the person diagnosed, and a loss of independence was endorsed as affecting quality of life. The distinct perspectives of diagnosed persons and care partners regarding disease impact differed notably for bvFTD/Pick’s disease. Participating independently in a range of activities, within the home, outside the home, and with other people, were reported as challenging for people living with FTD, underscoring the degree to which the lives of these individuals are affected even at the mild and moderate stages of disease. Overall, by heeding the perspectives of those living with FTD, we can begin to design more meaningful research studies, provide better care, and develop therapies that improve quality of life.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/08919887221119976

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists haven’t been fetched yet

References 37 · Cited by 17

Research works printed but not linked: 33

  1. 10.1177/2168479017716715 · DOI
  2. U.S. Food and Drug Administration, 2016, PDUFA V: Fiscal Years 2013 - 2017
  3. 10.1186/s13023-017-0718-x · DOI
  4. 10.1016/j.jval.2017.05.015 · DOI
  5. 10.1016/j.biopsych.2015.03.028 · DOI
  6. 10.4088/JCP.10m06382oli · DOI · Paper page
  7. 10.1212/WNL.0000000000002638 · DOI
  8. 10.1212/CON.0000000000000300 · DOI
  9. 10.1017/s0317167100054147 · DOI
  10. 10.1080/13607863.2018.1433634 · DOI
  11. 10.1007/s00702-021-02379-z · DOI
  12. 10.1016/j.gerinurse.2013.05.001 · DOI
  13. 10.1080/02687030244000716 · DOI
  14. 10.1212/WNL.50.6.1637 · DOI
  15. 10.1002/alz.12494 · DOI
  16. 10.1176/appi.neuropsych.21.3.299 · DOI
  17. 10.1212/wnl.51.6.1546 · DOI · Paper page
  18. 10.1212/CPJ.0000000000000738 · DOI
  19. 10.1093/brain/awab365 · DOI
  20. 10.3389/fnins.2019.00658 · DOI
  21. 10.1136/jnnp.70.3.323 · DOI
  22. 10.1136/jnnp-2020-322987 · DOI · Paper page
  23. 10.3109/09540261.2013.776949 · DOI
  24. 10.1177/08919887221090213 · DOI
  25. 10.1016/j.concog.2011.09.005 · DOI
  26. 10.1159/000511329 · DOI
  27. 10.1016/j.cognition.2015.02.001 · DOI
  28. 10.1093/brain/awl145 · DOI · Paper page
  29. 10.1016/S0278-2626(03)002277-X · DOI
  30. 10.1007/978-3-030-51140-1_4 · DOI
  31. 10.1016/j.cortex.2018.02.012 · DOI
  32. 10.1176/appi.neuropsych.17120349 · DOI
  33. 10.1007/978-3-030-51140-1_10 · DOI

Metadata

Authors
Barker, M. S., Dodge, S. G., Niehoff, D., Denny, S., Dacks, P. A., Dickinson, S., Cosentino, S., & Wheaton, D. K. H.
Affiliations
  • Columbia University Irving Medical Center (US)
  • Association for Frontotemporal Degeneration (US)
  • FTD Disorders Registry, LLC, King of Prussia, PA, USA
Corresponding author
Wheaton, Dianna K.H.
Venue
Journal of Geriatric Psychiatry and Neurology
Published
2022-08-09
Volume
36
Issue
3
Pages
201-214
ISSN
  • 0891-9887 (ISSN-L)
  • 1552-5708
OpenAlex
W4290770827
Cited by
17
References
37
Citations by year
2026: 6 · 2025: 7 · 2024: 4
FWCI
1.79
Type
journal article
Language
en
Open access
Locations
  • Journal of Geriatric Psychiatry and Neurology (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
Association for Frontotemporal Degeneration (FTD Insights Postdoctoral Fellowship)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords
frontotemporal lobar degeneration, diagnostic journey, symptom experience, quality of life, loss of independence, caregiver perspectives, behavioral variant frontotemporal dementia, Pick's disease, cognitive symptoms, language symptoms, distress
MeSH terms
Atrophy, Humans, Quality of Life, Neurodegenerative Diseases, Frontotemporal Dementia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Living With Frontotemporal Degeneration: Diagnostic Journey, Symptom Experiences, and Disease Impact. https://app.cochat.ai/papers/10.1177/08919887221119976
The paper
Barker, M. S., Dodge, S. G., Niehoff, D., Denny, S., Dacks, P. A., Dickinson, S., Cosentino, S., & Wheaton, D. K. H. (2023). Living With Frontotemporal Degeneration: Diagnostic Journey, Symptom Experiences, and Disease Impact. Journal of Geriatric Psychiatry and Neurology. https://doi.org/10.1177/08919887221119976